Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
01/08/2014 | CN103502237A FAAH inhibitors |
01/08/2014 | CN103502217A Diarylacetylene hydrazide containing tyrosine kinase inhibitors |
01/08/2014 | CN103501788A Pyridopyrazine derivatives and their use |
01/08/2014 | CN103497190A Derivative of imidazole [4, 5-f] [1, 10] phenanthroline as well as preparation method and application thereof |
01/08/2014 | CN103497189A 1-OH-3,4:9,10-tetracarboxylic diimide and synthesis method as well as application thereof in measurement of fluorine content |
01/08/2014 | CN103497188A Compounds modulating c-fms and/or c-kit activity and uses therefor |
01/08/2014 | CN103497187A Method for improving chemical purity of moxifloxacin side chain on industry |
01/08/2014 | CN103497186A Alcoxyimino-contained substituted naphthyridine-carboxylic acid derivatives and preparation method thereof |
01/08/2014 | CN103497185A Pyrazolo(3, 4-B)pyridine derivatives as phosphodiesterase inhibitors |
01/08/2014 | CN103497184A Pyrrolo-and thiazolo-pyridine compounds as HIF modulators |
01/08/2014 | CN103497181A Benzoperhydroazepinone compounds as glycogen phosphorylase inhibitors as well as preparation method and medical application thereof |
01/08/2014 | CN103497154A Water-soluble perylene imide compounds, usage as DNA intercalator, and applications thereof in growth inhibition of cancer cells |
01/08/2014 | CN102015691B Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitors |
01/07/2014 | US8624023 Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediates |
01/07/2014 | US8623898 Glycine transporter inhibiting substances |
01/07/2014 | US8623889 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof |
01/07/2014 | US8623869 Compounds useful as inhibitors of ATR kinase |
01/07/2014 | US8623862 Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics |
01/07/2014 | CA2778886C N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors |
01/07/2014 | CA2712574C Polymorphic form of a [1,2,4]triazolo[4,3-a]pyridine derivative for treating inflammatory diseases |
01/07/2014 | CA2611438C Cyclic anilino-pyridinotriazines |
01/07/2014 | CA2602800C Pyrazolopyridines and analogs thereof |
01/03/2014 | WO2014005150A1 Crystalline forms of l-(2-((lr,3s,5r)-3-( (2 -fluoro-3 - (trifluoromethoxy) phenyl) carbamoyl) - 2 -azabicycl o [3.1.0] hexan- 2 -yl) - 2 -oxoethyl) - 5 -methyl - 1h - pyrazolo [3, 4 -c] pyridine - 3 - carboxami de and salts thereof |
01/03/2014 | WO2014005129A1 Cyanoguanidines and their use as antiviral agents |
01/03/2014 | WO2014004416A1 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
01/03/2014 | WO2014003098A1 Tricyclic compound |
01/03/2014 | WO2014002059A1 CRYSTALLINE FORMS OF 1-(2-((1R,3S,5R)-3-(((R)-1-(3-chloro-2-fluorophenyl)ethyl)carbamoyl)-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-1Hpyrazolo[3,4-c]pyridine-3-carboxamide |
01/03/2014 | WO2014002057A1 Pyrrolidine derivatives and their use as complement pathway modulators |
01/03/2014 | WO2014002053A1 Pyrrolidine derivatives and their use as complement pathway modulators |
01/03/2014 | WO2014001775A1 Antimicrobial compounds |
01/03/2014 | WO2014001377A1 5-azaindazole compounds and methods of use |
01/03/2014 | WO2014001348A1 Alkaloid derivatives of cytisine used in the treatment of diseases of the central nervous system |
01/03/2014 | WO2014000587A1 Phenanthroindolizidine alkaloid c14 aminated derivatives and preparation and anti-plant virus activity thereof |
01/03/2014 | WO2014000586A1 Phenanthroindolizidine alkaloid derivates and salt thereof as well as preparation, plant-virus resisting activity, and anti-cancer activity of phenanthroindolizidine alkaloid derivates and salt thereof |
01/03/2014 | WO2013140319A9 Crystalline form of a succinate salt |
01/03/2014 | CA2877326A1 Cyanoguanidines and their use as antiviral agents |
01/03/2014 | CA2876993A1 Pyrrolidine derivatives and their use as complement pathway modulators |
01/03/2014 | CA2876240A1 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
01/03/2014 | CA2876157A1 Antimicrobial compounds |
01/02/2014 | US20140005400 New azacyclic compounds |
01/02/2014 | US20140005383 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
01/02/2014 | US20140005370 Molecular glasses with functionalizable groups |
01/02/2014 | US20140005292 NOVEL COMPOUND HAVING alpha-CYANOACRYLATE STRUCTURE, DYE, AND COLORED PHOTOSENSITIVE COMPOSITION |
01/02/2014 | US20140005221 Ring-fused compound |
01/02/2014 | US20140005220 Beta carboline derivatives useful in the treatment of proliferative disorders |
01/02/2014 | US20140005215 Selective Opioid Compounds |
01/02/2014 | US20140005213 Triazolopyridine compounds as pim kinase inhibitors |
01/02/2014 | US20140005206 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
01/02/2014 | US20140005201 Tricyclic imidazole compounds as PDE10 inhibitors |
01/02/2014 | US20140005197 Inhibitors of influenza viruses replication |
01/02/2014 | US20140005193 Benzoimidazoles as prolyl hydroxylase inhibitors |
01/02/2014 | US20140005192 Inhibitors of influenza viruses replication |
01/02/2014 | US20140005188 Pyrido[3,4-b]pyrazine derivatives as syk inhibitors |
01/02/2014 | US20140005170 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
01/02/2014 | US20140005168 5-azaindazole compounds and methods of use |
01/02/2014 | US20140005166 Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors |
01/02/2014 | US20140005165 Substituted 3-azabicyclo[3.1.0]hexane derivatives useful as ccr2 antagonists |
01/02/2014 | US20140005164 Wnt pathway antagonists |
01/02/2014 | US20140005163 1h-imidazo[4,5-c]quinolinone derivatives |
01/02/2014 | US20140005103 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
01/02/2014 | US20140004455 Electrophotographic photosensitive member, method for producing electrophotographic photosensitive member, process cartridge, electrophotographic apparatus, and imide compound |
01/02/2014 | US20140004111 Polycyclic agents for the treatment of respiratory syncytial virus infections |
01/02/2014 | US20140001460 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same |
01/02/2014 | US20140001443 Organic light-emitting compound and organic light-emitting device including the same |
01/01/2014 | EP2679588A1 Asymmetric synthesis method, related raw material and preparation method of (s,s)-2,8-diazabicyclo[4,3,0]nonane |
01/01/2014 | EP2679583A1 Mesoionic pesticides |
01/01/2014 | EP2678339A1 Methods and compositions for treating -thalassemia and sickle cell disease |
01/01/2014 | EP2678338A1 Compounds and compositions as trk inhibitors |
01/01/2014 | EP2678337A1 2-amino-naphthyridine derivatives |
01/01/2014 | EP2678329A1 Triazolopyridine compounds as pim kinase inhibitors |
01/01/2014 | EP2678075A1 Solid forms of a pharmaceutically active substance |
01/01/2014 | CN103493239A Organic electroluminescent element |
01/01/2014 | CN103492388A Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors |
01/01/2014 | CN103492387A Perylene-based semiconducting materials |
01/01/2014 | CN103492386A Novel compound useful for the treatment of degenerative and inflammatory diseases |
01/01/2014 | CN103492385A Novel compound useful for the treatment of degenerative and inflammatory diseases |
01/01/2014 | CN103492384A Compounds and compositions as trk inhibitors |
01/01/2014 | CN103492383A Materials for organic electroluminescent devices |
01/01/2014 | CN103492382A Inhibitors of influenza viruses replication |
01/01/2014 | CN103492381A Inhibitors of influenza viruses replication |
01/01/2014 | CN103492377A Triazolopyridine compounds as PIM kinase inhibitors |
01/01/2014 | CN103492376A Bicyclic heterocycle compounds and their uses in therapy |
01/01/2014 | CN103492372A Androgen receptor modulating carboxamides |
01/01/2014 | CN103484105A Red light organic electroluminescent materials and devices |
01/01/2014 | CN103483339A Simple synthesis method of 9H-pyridino-[2, 3-b] indole |
01/01/2014 | CN103483338A Triazolopyridine derivatives as p38 map kinase inhibitors |
01/01/2014 | CN103483337A Fluorinated isoquinoline [a] pyrrole compounds and preparation method thereof |
01/01/2014 | CN103483321A Alkyl linked pyridoin-quinolinone compounds and preparation method as well as application thereof |
01/01/2014 | CN103483315A 7-(3-aminomethyl-4-alkoxyimino-1-piperidyl)-1-[(1R,2S)-2-fluorocyclopropyl] quinolone carboxylic acid compounds and preparation method thereof |
01/01/2014 | CN103483267A Diverse arylimidazole quaternary ammonium salt, preparation method and application thereof |
01/01/2014 | CN103483263A Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof |
01/01/2014 | CN103483255A Fluorinated isoquinoline compounds and preparation method thereof |
01/01/2014 | CN103483251A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
01/01/2014 | CN102036987B Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- a] pyridines, and preparation and therapeutic use thereof |
12/31/2013 | US8618299 Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof |
12/31/2013 | US8618298 Perylene tetracarboximide derivatives for photovoltaic devices |
12/31/2013 | US8618297 Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions |
12/31/2013 | US8618288 Pyrimidine compounds as serotonin receptor modulators |
12/31/2013 | US8618152 Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases |
12/31/2013 | US8618132 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |